Maureen Mealy: Raising Awareness for a Rare Disease and Moving Treatment Forward

Video

There are rare diseases and then there are ultra rare diseases. Neuromyelitis optica falls into the latter category but with a considerable amount of research behind it and a defined target to look at there has been success seen in finding treatments with more work being done every day.

There are rare diseases and then there are ultra rare diseases. Neuromyelitis optica falls into the latter category, but with a considerable amount of research behind it and a defined target to look at, there has been some early success in finding treatments with more work being done every day.

Speaking at the annual meeting of the Consortium of Multiple Sclerosis Centers Maureen A. Mealy, RN, BSN, MSCN, discussed how the research in this condition is moving forward and what that can mean for patient care. Mealy credited the Guthy-Jackson Charitable Foundation with being one of the organizations leading the charge to help find a treatment for this rare condition.

Related Videos
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Gestational Low-Dose Aspirin Does Not Increase Risk of IBD Flares in Women
Riha Bhatt, MD: Mimickers and Concurrent Diseases in Pediatric IBD
Elizabeth Spencer, MD: Precision Medicine in Pediatric IBD
Anita Clayton, MD: Zuranolone for Postpartum Depression
Mikkael Sekeres, MD:
Lynn Malec, MD: FVIII Therapy Improves Levels in Pediatric Patients with Hemophilia A
© 2024 MJH Life Sciences

All rights reserved.